IRIS Accounts Production v26.1.10.61 08593620 Board of Directors 1.4.25 31.3.26 31.3.26 false true false false true false Fair value model iso4217:GBP iso4217:USD iso4217:EUR xbrli:shares xbrli:pure utr:tonnes utr:kWh 08593620 2025-03-31 08593620 2026-03-31 08593620 2025-04-01 2026-03-31 08593620 2024-03-31 08593620 2024-04-01 2025-03-31 08593620 2025-03-31 08593620 ns15:EnglandWales 2025-04-01 2026-03-31 08593620 ns14:PoundSterling 2025-04-01 2026-03-31 08593620 ns10:Director1 2025-04-01 2026-03-31 08593620 ns10:PrivateLimitedCompanyLtd 2025-04-01 2026-03-31 08593620 ns10:SmallEntities 2025-04-01 2026-03-31 08593620 ns10:AuditExempt-NoAccountantsReport 2025-04-01 2026-03-31 08593620 ns10:SmallCompaniesRegimeForDirectorsReport 2025-04-01 2026-03-31 08593620 ns10:SmallCompaniesRegimeForAccounts 2025-04-01 2026-03-31 08593620 ns10:FullAccounts 2025-04-01 2026-03-31 08593620 ns10:Director2 2025-04-01 2026-03-31 08593620 ns10:RegisteredOffice 2025-04-01 2026-03-31 08593620 ns5:CurrentFinancialInstruments 2026-03-31 08593620 ns5:CurrentFinancialInstruments 2025-03-31 08593620 ns5:ShareCapital 2026-03-31 08593620 ns5:ShareCapital 2025-03-31 08593620 ns5:RetainedEarningsAccumulatedLosses 2026-03-31 08593620 ns5:RetainedEarningsAccumulatedLosses 2025-03-31 08593620 ns5:FurnitureFittings 2025-04-01 2026-03-31 08593620 ns5:ComputerEquipment 2025-04-01 2026-03-31 08593620 ns5:FurnitureFittings 2025-03-31 08593620 ns5:ComputerEquipment 2025-03-31 08593620 ns5:FurnitureFittings 2026-03-31 08593620 ns5:ComputerEquipment 2026-03-31 08593620 ns5:FurnitureFittings 2025-03-31 08593620 ns5:ComputerEquipment 2025-03-31 08593620 ns5:WithinOneYear ns5:CurrentFinancialInstruments 2026-03-31 08593620 ns5:WithinOneYear ns5:CurrentFinancialInstruments 2025-03-31

REGISTERED NUMBER: 08593620 (England and Wales)

UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2026

FOR

NURSE EXPERT WITNESS LIMITED

NURSE EXPERT WITNESS LIMITED (REGISTERED NUMBER: 08593620) |

CONTENTS OF THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2026

Page |

| Company Information | 1 |

| Balance Sheet | 2 |

| Notes to the Financial Statements | 3 |

| NURSE EXPERT WITNESS LIMITED |

COMPANY INFORMATION

FOR THE YEAR ENDED 31 MARCH 2026

| DIRECTORS: | D Aslan

| C Aslan

| REGISTERED OFFICE: | 30 Riverside Road

| Shoreham-By-Sea

| West Sussex

| BN43 5RB

| REGISTERED NUMBER: | 08593620 (England and Wales)

| ACCOUNTANTS: | Galloways Accounting Limited

| 15 West Street

| Brighton

| East Sussex

| BN1 2RL

NURSE EXPERT WITNESS LIMITED (REGISTERED NUMBER: 08593620) |

BALANCE SHEET

31 MARCH 2026

| 2026 | 2025 |

| Notes | £ | £ | £ | £ |

FIXED ASSETS

Tangible assets | 4 | 25,647 |  | 30,576 |  |

Investment property | 5 | 25,606 |  | 25,606 |  |

51,253 |  | 56,182 |  |

CURRENT ASSETS

Debtors | 6 | 13,894 |  | 18,955 |  |

Cash at bank | 44,271 |  | 18,988 |  |

58,165 |  | 37,943 |  |

CREDITORS

Amounts falling due within one year | 7 | 39,936 |  | 37,619 |  |

NET CURRENT ASSETS | 18,229 |  | 324 |  |

TOTAL ASSETS LESS CURRENT LIABILITIES | 69,482 |  | 56,506 |  |

PROVISIONS FOR LIABILITIES | 4,875 |  | - |  |

NET ASSETS | 64,607 |  | 56,506 |  |

CAPITAL AND RESERVES

Called up share capital | 2 |  | 2 |  |

Retained earnings | 64,605 |  | 56,504 |  |

SHAREHOLDERS' FUNDS | 64,607 |  | 56,506 |  |

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2026.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2026 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 2 June 2026 and were signed on its behalf by:

D Aslan - Director

NURSE EXPERT WITNESS LIMITED (REGISTERED NUMBER: 08593620) |

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2026

1. | STATUTORY INFORMATION

| Nurse Expert Witness Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

| The presentation currency of the financial statements is the Pound Sterling (£).

2. | ACCOUNTING POLICIES

| Basis of preparing the financial statements

| These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

| Turnover

| Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

| Turnover represents invoiced sales for the provision of nurse expert witness services to the legal sector net of VAT. Turnover is recognised upon the performance of that service.

| Tangible fixed assets

| Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

| Fixtures and fittings | - | 25% on reducing balance

| Office equipment | - | 25% on reducing balance

| Tangible fixed assets are stated at cost (or deemed cost) or valuation less accumulated depreciation and accumulated impairment losses. Cost includes costs directly attributable to making the asset capable of operating as intended.

| Investment property

| Investment property is initially recognised as cost and then subsequently at most recent valuation. Any aggregate surplus or deficit arising from changes in fair value is recognised in profit or loss.

| Taxation

| Taxation for the year comprises current tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

| Current taxation assets and liabilities are not discounted.

| Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

| Hire purchase and leasing commitments

| Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

| Financial instruments

| Debtors and creditors with no stated interest rate and receivable or payable within one year are recorded at transaction price. Any losses arising from impairment are recognised in the profit and loss account in other administrative expenses.

3. | EMPLOYEES AND DIRECTORS

| The average number of employees during the year was 1 (2025 - 2 ) .

NURSE EXPERT WITNESS LIMITED (REGISTERED NUMBER: 08593620) |

NOTES TO THE FINANCIAL STATEMENTS - continued

FOR THE YEAR ENDED 31 MARCH 2026

4. | TANGIBLE FIXED ASSETS

| Fixtures |

| and |  | Office |

| fittings |  | equipment |  | Totals

£ | £ | £ |

| COST

| At 1 April 2025 | 14,310 |  | 31,050 |  | 45,360 |  |

| Additions | - |  | 2,660 |  | 2,660 |  |

| At 31 March 2026 | 14,310 |  | 33,710 |  | 48,020 |  |

| DEPRECIATION

| At 1 April 2025 | 3,903 |  | 10,881 |  | 14,784 |  |

| Charge for year | 2,240 |  | 5,349 |  | 7,589 |  |

| At 31 March 2026 | 6,143 |  | 16,230 |  | 22,373 |  |

| NET BOOK VALUE

| At 31 March 2026 | 8,167 |  | 17,480 |  | 25,647 |  |

| At 31 March 2025 | 10,407 |  | 20,169 |  | 30,576 |  |

5. | INVESTMENT PROPERTY

| Total

£ |

| FAIR VALUE

| At 1 April 2025

| and 31 March 2026 | 25,606 |  |

| NET BOOK VALUE

| At 31 March 2026 | 25,606 |  |

| At 31 March 2025 | 25,606 |  |

6. | DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |

2026 | 2025 |

£ | £ |

| Trade debtors | 13,524 |  | 18,600 |  |

| Other debtors | - |  | 225 |  |

| Prepayments and accrued income | 370 |  | 130 |  |

13,894 |  | 18,955 |  |

7. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |

2026 | 2025 |

£ | £ |

| Trade creditors | 330 |  | 1,710 |  |

| Tax | 22,826 |  | 11,447 |  |

| VAT | 8,783 |  | 6,893 |  |

| Directors' current accounts | 6,147 |  | 15,819 |  |

| Accruals and deferred income | 1,850 |  | 1,750 |  |

39,936 |  | 37,619 |  |